LWLijun Wang

Lijun Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lijun Wang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Jianming Wang

    Department of Ophthalmology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China

    5 shared publications
  • Chao Sun

    Department of Ophthalmology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China

    2 shared publications
  • Dingying Liao

    Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an 710004, China

    2 shared publications
  • Hongsong Li

    Department of Ophthalmology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China

    2 shared publications
  • Lin Zhao

    Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an 710004, China

    2 shared publications
  • Xiting Yang

    Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xiwu Road, Xi'an 710004, China

    2 shared publications

Latest Publications

  • Open Access

    Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition

    by Lijun Wang, Hongsong Li, Lei Xiong, Chao Sun, Jianming Wang

    Fibrosis after glaucoma drainage surgery (GDS) is the main factor behind glaucoma surgery failures. Previous studies showed that cereblon (CRBN) protein is involved in tissue differentiation, although its role in glaucoma remains unknown. Herein we explored the role of CRBN and its ligand thalidomide (THD) in fibrosis after GDS. Using a rat GDS model and TGF-β2-induced cell model, we investigated the functions of CRBN and THD. CRBN expression in Tenon capsule tissue was detected using immunofluorescence. Filtering bleb survival was monitored after surgery. Protein levels of α‑smooth muscle actin (SMA), fibronectin (FN), and proliferating cell nuclear antigen (PCNA) were measured by Western blotting and immunohistochemistry. Activation of the nuclear factor (NF)‑κB pathway was evaluated via detecting P65 and p‑P65 levels. CRBN expression was upregulated in Tenon capsule tissue after GDS. THD treatment significantly attenuated CRBN expression. Moreover, THD dose-dependently inhibited TGF-β2-induced cell proliferation. Western blotting confirmed that THD suppresses TGF-β2-induced transdifferentiation and proliferation of human Tenon fibroblasts. In vivo, topical THD application prolonged filtering bleb survival and restrained α-SMA expression. Mechanistically, THD inhibited P65 phosphorylation, thereby preventing the activation of the NF-κB pathway. CRBN is a key protein regulating fibrosis following GDS. THD exerts anti-fibrotic effects by targeting CRBN and inhibiting the NF-κB pathway. These findings unveil a novel intervention target, CRBN, for attenuating fibrogenesis after GDS.

  • Open Access

    Pirfenidone Attenuates the EMT Process and the Secretion of VEGF in TGF‐β2‐Induced ARPE‐19 Cells via Inhibiting the Activation of the NF‐κB/Snail Signaling Pathway

    by Hongsong Li, Lijun Wang, Meilin Shao, Meimei Ren, Wenyi Zhang, Jian Zhou, Jianming Wang

    Aim. Pirfenidone (PFD), an antifibrotic drug, has various beneficial functions such as antioxidant, antifibrotic, and anti‐inflammatory effects. This study aimed to explore the molecular mechanisms underlying how PFD modulates retinal pigment epithelial (RPE) cells involved in neovascularization and subretinal fibrosis. Methods. ARPE‐19 cell lines were treated with transforming growth factor‐beta 2 (TGF‐β2) alone or in combination with PFD. RPE cell viability, as a consequence of PFD use, was determined by the CCK‐8 assay. Cell migration was assessed by the wound closure assay and quantified by the Image J software. Protein expression of the following markers was measured by the western blot analysis: an epithelial cell marker and E‐cadherin; mesenchymal cell markers, fibronectin, matrix metalloprotein‐9 (MMP‐9), and alpha‐smooth muscle actin (α‐SMA); a fibrotic marker and connective tissue growth factor (CTGF); an angiogenesis marker and vascular endothelial growth factor (VEGF); NF‐κB/Snail. The mRNA levels of fibronectin and α‐SMA were determined by quantitative real‐time PCR. VEGF was quantitatively measured by the enzyme‐linked immunosorbent assay. Results. The cell viability assay revealed that PFD had no significant cytotoxic effect on RPE cells at concentrations of less than 1 mg/mL. The cell scratch assay showed that TGF‐β2 stimulation significantly improved the migration of RPE cells and that PFD attenuated this effect. PFD significantly inhibited the TGF‐β2‐induced protein expression of E‐cadherin and increased the TGF‐β2‐induced protein expression of fibronectin, MMP‐9, α‐SMA, CTGF, and VEGF in ARPE‐19 cells. The mRNA expression of fibronectin and α‐SMA was inhibited by PFD in TGF‐β2‐inducedARPE‐19 cells. Additionally, the increased intracellular and supernatant expression of VEGF protein was suppressed by PFD. Mechanistically, RPE cells treated with PFD + TGF‐β2 exhibited a decrease in phosphorylation of the NF‐κB P65 subunit and activation of Snail, compared with the RPE cells treated with TGF‐β2 alone. Conclusion. PFD ameliorated TGF‐β2‐induced neovascularization and fibrosis by suppressing the NF‐κB/Snail signaling pathway. Therefore, PFD may be a potential drug in the treatment of age‐related macular degeneration.


  • Open Access

    Comparison of Outcomes after Phacoemulsification with Two Different Corneal Incision Distances Anterior to the Limbus

    by Lijun Wang, Lin Zhao, Xiting Yang, Yi Zhang, Dingying Liao, Jianming Wang

    Purpose. To compare visual performance and visual quality outcomes after phacoemulsification with two different clear corneal incision (CCI) distances anterior to the limbus in senile cataract patients. Methods. Retrospective case series. Patients who had undergone phacoemulsification were divided into two groups according to the CCI distances anterior to the limbus. The CCI distances in group A range from 1 mm to 1.5 mm, while those in group B range from 0.5 mm to 1 mm. The visual acuity, refraction, surgically induced astigmatism (SIA), corneal aberrations, anterior segment parameters, and subjective vision quality were evaluated. Results. This study enrolled 54 eyes, with 27 eyes per group. Both groups had significant improvement in postoperative uncorrected visual acuity (UCVA) and corrected distance visual acuity (CDVA) (P<0.05). There were no statistically significant between-group differences in postoperative UDVA, CDVA, SIA, corneal aberrations, anterior segment parameters, or VF-QOL questionnaire performance (P>0.05). Conclusions. The phacoemulsification with CCI distances ranging from 0.5 mm to 1.5 mm is an effective and safe therapy to senile cataract. The CCI distance anterior to the limbus that ranges from 0.5 mm to 1.5 mm is recommended for routine phacoemulsification.


  • [Effect of different clear corneal incision sites on surgery efficacy and anterior segment parameters in patients undergoing phacoemulsification].

    by Lijun Wang, Xiting Yang, Yi Zhang, Dingying Liao, Lin Zhao, Jianming Wang

    To determine the safe distance range of clear corneal incision (CCI) from the corneal limbus and how different CCI sites affect surgery efficacy and anterior segment parameters in patients undergoing phacoemulsification. This retrospective case-control study was conducted in 44 patients (44 eyes) undergoing phacoemulsification and IOL implantation. The patients were divided into two groups with CCI distances ranging from 1 mm to 1.5 mm (group A, n= 22) and from 0.5 mm to 1.0 mm (group B, n= 22). The visual acuity, surgically induced astigmatism (SIA), corneal aberration, and anterior segment parameters were analyzed. Compared with the preoperative data, all the patients showed significant improvements in the postoperative uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), anterior chamber depth (ACD), and anterior chamber angle (ACA) after the surgery (P < 0.05). No significant differences were found between the two groups in postoperative UCVA, BCVA, SIA, total corneal aberration RMS, lower- and higher-order aberration RMS, spherical aberration (Z40), horizontal three leaf clover (Z33), vertical three leaf clover(Z3-3), horizontal coma(Z31), vertical coma(Z3-1), ACD, ACA, anterior chamber volume, or central corneal thickness (P>0.05). Phacoemulsification is an effective therapy for cataract with a CCI distance range either of 1-1.5 mm or 0.5-1.0 mm. These two CCI distance ranges produce no significant differences in the visual quality following phacoemulsification, indicating that a CCI distance range of 0.5-1.5 mm can be safe for phacoemulsification.

  • Open Access

    Comparison of efficacy between coaxial microincision and standard-incision phacoemulsification in patients with age-related cataracts: a meta-analysis

    by Lijun Wang, Xiao Xiao, Lin Zhao, Yi Zhang, Jianming Wang, Aiyi Zhou, Jianchao Wang, Qian Wu

    Incision size plays a critical role in the efficacy of cataract surgery, but the available evidence on ideal incision size is inconsistent. In this study, we conducted a meta-analysis to evaluate the efficacy of coaxial microincisional phacoemulsification surgery (MICS) compared with that of standard-incision phacoemulsification surgery (SICS) in patients with age-related cataracts. The Cochrane Library (Wiley Online Library), PubMed, Medline, National Knowledge Infrastructure (CNKI), and VIP databases were searched to identify reports of clinical randomized controlled trials (RCTs) comparing MICS to SICS for the treatment of age-related cataracts. The outcomes of interest included surgically induced astigmatism (SIA), effective phacoemulsification time (EPT), central corneal thickness (CCT), endothelial cell count (ECC), endothelial cell count loss (ECC Loss %), and average ultrasonic energy (AVE). Eleven RCT studies were included in this meta-analysis. No statistically significant differences were observed in EPT (Z = 1.29, P > 0.05), CCT (1 day: Z = 1.37, P > 0.05; 7 days: Z = 0.75, P > 0.05; 30 days: Z = 0.38, P > 0.05; 90 days: Z = 0.29, P > 0.05), ECC (7 days: Z = 1.13, P > 0.05; 30 days: Z = 1.42, P > 0.05) or ECC Loss % (7 days: Z = 0.24, P > 0.05; 30 days: Z = 0.06, P > 0.05; 90 days: Z = 0.10, P > 0.05) between MICS and SICS. However, statistically significant differences were found in AVE (Z = 4.19, P < 0.0001) and SIA (1 day: Z = 10.33, P < 0.00001; 7 days: Z = 10.71, P < 0.00001; 30 days: Z = 10.95, P < 0.00001; 90 days: Z = 2.21,- P < 0.01) between MICS and SICS. Compared with SICS, MICS can reduce short-term and long-term SIA, but it does not differ in safety outcomes or in the time required for surgery.